NR4A1 and neoplasm: In fact, there is evidence that patients with tumours of good biological risk (low grade, low proliferation and increased expression of hormone receptors) have little or no benefit from chemotherapy, even in the presence of metastatic lymph nodes, but the contrary is true [62].